Pavel Šlampa

2.4k total citations
92 papers, 916 citations indexed

About

Pavel Šlampa is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Pavel Šlampa has authored 92 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 31 papers in Genetics and 26 papers in Oncology. Recurrent topics in Pavel Šlampa's work include Glioma Diagnosis and Treatment (31 papers), Brain Metastases and Treatment (24 papers) and Advanced Radiotherapy Techniques (18 papers). Pavel Šlampa is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Brain Metastases and Treatment (24 papers) and Advanced Radiotherapy Techniques (18 papers). Pavel Šlampa collaborates with scholars based in Czechia, United States and Slovakia. Pavel Šlampa's co-authors include Tomáš Kazda, Radim Jančálek, Petr Pospíšil, M Slavík, Petr Burkoň, Radek Lakomý, Martin Bulik, Ondřej Slabý, Martin Smrčka and Jiří Šáňa and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Carcinogenesis.

In The Last Decade

Pavel Šlampa

77 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavel Šlampa Czechia 15 403 340 227 200 197 92 916
Tomáš Kazda Czechia 16 434 1.1× 388 1.1× 259 1.1× 166 0.8× 189 1.0× 101 1000
Robert Nordal Canada 14 330 0.8× 413 1.2× 181 0.8× 125 0.6× 88 0.4× 27 825
Tu Dan United States 15 182 0.5× 309 0.9× 151 0.7× 160 0.8× 190 1.0× 52 749
Guillaume Vogin France 17 133 0.3× 368 1.1× 272 1.2× 215 1.1× 125 0.6× 61 851
Ya-Yu Tsai United States 17 357 0.9× 555 1.6× 111 0.5× 216 1.1× 125 0.6× 72 1.0k
Markus W. Groß Germany 15 290 0.7× 218 0.6× 197 0.9× 173 0.9× 171 0.9× 24 866
Walter Curran United States 5 738 1.8× 404 1.2× 213 0.9× 158 0.8× 195 1.0× 8 940
Katsuyuki Shirai Japan 22 198 0.5× 672 2.0× 231 1.0× 277 1.4× 143 0.7× 102 1.3k
Toshihiko Iuchi Japan 20 580 1.4× 746 2.2× 188 0.8× 174 0.9× 122 0.6× 54 1.4k
Angela Mohr Germany 15 228 0.6× 270 0.8× 143 0.6× 115 0.6× 64 0.3× 25 559

Countries citing papers authored by Pavel Šlampa

Since Specialization
Citations

This map shows the geographic impact of Pavel Šlampa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Šlampa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Šlampa more than expected).

Fields of papers citing papers by Pavel Šlampa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Šlampa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Šlampa. The network helps show where Pavel Šlampa may publish in the future.

Co-authorship network of co-authors of Pavel Šlampa

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Šlampa. A scholar is included among the top collaborators of Pavel Šlampa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Šlampa. Pavel Šlampa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burkoň, Petr, Iveta Selingerová, Oldřich Coufal, et al.. (2025). Quality of life in early breast cancer patients after adjuvant accelerated partial-breast irradiation (APBI) in randomized trial. Scientific Reports. 15(1). 1387–1387.
2.
Burkoň, Petr, Iveta Selingerová, M Slavík, et al.. (2024). Toxicity of external beam accelerated partial-breast irradiation (APBI) in adjuvant therapy of early-stage breast cancer: prospective randomized study. Radiation Oncology. 19(1). 17–17. 2 indexed citations
3.
Apostolopoulos, Vasileios, et al.. (2024). Clear surgical margins as a prognostic indicator for disease recurrence, with no impact on survival rates in patients with myxofibrosarcoma. Scientific Reports. 14(1). 12232–12232. 1 indexed citations
5.
Burkoň, Petr, et al.. (2020). Stereotactic Body Radiotherapy of Lymph Node Oligometastases. Klinicka onkologie. 33(2). 114–122. 5 indexed citations
6.
Fadrus, Pavel, et al.. (2020). Targeted Radiotherapy of the Tumor Cavity after Surgical Resection of Aggressive Recurrent Brain Metastasis: A Case Report. Case Reports in Oncology. 13(1). 233–238. 1 indexed citations
7.
Kazda, Tomáš, Radek Lakomý, Petr Pospíšil, et al.. (2019). Current approaches to the radiotherapy of brain metastases from solid tumors. 13(4). 167–172. 1 indexed citations
8.
Sepši, Milan, et al.. (2018). Použití metody odstraňování artefaktů Metal Deletion Technique pro plánování radioterapii u pacientů s implantovanými kardiostimulátory. Klinicka onkologie. 31(6). 1 indexed citations
9.
Kazda, Tomáš, Petr Burkoň, Petr Pospíšil, et al.. (2018). Radiotherapy of glioblastoma 15 years after the landmark Stupp’s trial: more controversies than standards?. Radiology and Oncology. 52(2). 121–128. 45 indexed citations
10.
Slavík, M, Markéta Hermanová, Jiří Šáňa, et al.. (2018). Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition. Journal of Oral Pathology and Medicine. 47(9). 864–872. 5 indexed citations
12.
Pospíšil, Petr, Tomáš Kazda, Martin Bulik, et al.. (2017). Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study. Radiotherapy and Oncology. 122(3). 373–379. 34 indexed citations
13.
Ondráček, Jakub, Pavel Fadrus, Jiří Šáňa, et al.. (2017). Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. Anticancer Research. 37(3). 1099–1104. 14 indexed citations
14.
Pospíšil, Petr, Tomáš Kazda, Pavel Šlampa, & Radim Jančálek. (2016). Current strategy for treatment of high-grade gliomas. Neurologie pro praxi. 17(5). 287–292.
15.
Kazda, Tomáš, Petr Pospíšil, Petr Burkoň, et al.. (2015). Utilization of Prognostic Indexes for Patients with Brain Metastases in Daily Radiotherapy Routine – is the Complexity and Intricacy Still an Issue?. Klinicka onkologie. 28(5). 352–358. 2 indexed citations
16.
Kazda, Tomáš, Petr Pospíšil, Tomáš Procházka, et al.. (2015). Volumetric modulated arc therapy for hippocampal-sparing radiotherapy in transformed low-grade glioma: A treatment planning case report. Cancer/Radiothérapie. 19(3). 187–191. 3 indexed citations
17.
Lakomý, Radek, Pavel Fadrus, Pavel Šlampa, et al.. (2011). Výsledky multimodální léčby glioblastoma multiforme:konsekutivní série 86 pacientů diagnostikovaných v letech2003–2009. Klinicka onkologie. 24(2). 1 indexed citations
18.
Andrašina, Tomáš, Vlastimil Válek, Jiří Pánek, et al.. (2010). Multimodal Oncological Therapy Comprising Stents, Brachytherapy, and Regional Chemotherapy for Cholangiocarcinoma. Gut and Liver. 4(Suppl.1). S82–S82. 17 indexed citations
19.
Svoboda, Marek, Pavel Fabián, Markéta Palácová, et al.. (2007). Brain metastases in breast cancer: a retrospective cohort studyof 187 patients and prognostic markers determination.. Breast Cancer Research and Treatment. 106. 1 indexed citations
20.
Šlampa, Pavel. (2003). [Overview of concomitant chemoradiotherapy of solid tumors].. PubMed. 142 Suppl 1. 4–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026